2. Academic Validation
  3. Novel Mixed Serotonin Receptor Binder Compounds as 5‑HT2C Agonists for Treating Psychotic Disorders

Novel Mixed Serotonin Receptor Binder Compounds as 5‑HT2C Agonists for Treating Psychotic Disorders

  • ACS Med Chem Lett. 2025 Jul 29;16(8):1505-1506. doi: 10.1021/acsmedchemlett.5c00427.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40832520 DOI: 10.1021/acsmedchemlett.5c00427
Abstract

Provided herein are novel mixed serotonin receptor binder compounds as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating psychotic disorders, and processes for preparing such compounds.

Figures
Products